Semaglutide effectively treats liver disease in two thirds of patients, research finds

Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup